Catalyst Wire Dossier Catalyst Wire Dossier

Maralixibat

maralixibat · Mirum Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Maralixibat, covering 2019-03-18 to 2026-06-23. Get the full timeline:

Most recent: Clinical Trial Results: An Extension Study of Maralixibat in Patients With Progressive Familial Intrahepatic Cholestasis (PFIC) [Phase 3]

See pricing